ArticleCureus2025
Shaking in Darkness: Posterior Reversible Encephalopathy Syndrome (PRES)-Induced Acute Bilateral Blindness and Seizures.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a neurologic disorder that causes acute or subacute cerebral edema, brain capillary leakage, and a hyperperfusion encephalopathy that results in presenting symptoms of headache, vision changes, seizure activity, altered mentation, nausea or vomiting, or focal neurologic deficits. We describe a case of PRES in the setting of severe hypertension presenting with total blindness and seizure activity in a patient with multiple risk factors. The patient had previous episodes of PRES in the past that led to the development of a seizure disorder. We also provide a summarization table of PRES pathophysiology, symptoms, risk factors, diagnostics, treatment, and sequelae. Early consideration and expedited diagnosis of PRES are paramount, as seizures and permanent deficits are avoidable with early treatment and intervention. Seizures occur in the majority of patients presenting with PRES and are associated with an increased risk of developing epilepsy, more so than those following strokes. Timely anti-hypertensives as well as anti-convulsant therapy form the basis of treatment for PRES, allowing for prompt treatment and hopefully avoidance of long-term sequelae, including seizure disorders and permanent neurologic deficits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.